|
|
Volume 6, Issue 7, July 1999, in PDF
|
   |
Article 129: Pediatric Trials On the Verge
- As FDAMA Section 111 approaches, investigative sites and CROs are rapidly building capabilities to exploit the expected growth in pediatric clinical trials.
- At this time, major medical centers appear to be the best positioned investigative site segment to grab the pediatric clinical trials market.
Article 130: At Last! Development Cycle Times Shorten
- Reversing a 12-year trend, clinical phase (I-III) durations from 1996 to 1998 are 18% faster. In that same period, regulatory approval times have declined by 30%.
- Sponsors will need to continuously improve collaborative effectiveness with CROs and investigative sites to maintain and exceed clinical cycle time acceleration
Article 131: CentreStage Europe: European CRO Market Outpaces US Market
- CRO market growth in the US appears to be slowing. The contract clinical services market is growing at a faster rate in Europe. As a result, US-based CROs are now diriving rapid expansion into Europe through acquisition.
Article 132: Eye On Urinary Incontinence
- It is estimated that 200 million people suffer from urinary incontinence. CenterWatch editorial discusses 17 drugs Urinary Incontinence in clinical testing.
Price: $59.00
|
|
|
